Commission Regulation (EC) No 668/2009 of 24 July 2009 implementing Regulation (EC) No 1394/2007 of the European Parliament and of the Council with regard to the evaluation and certification of quality and non-clinical data relating to advanced therapy medicinal products developed by micro, small and medium-sized enterprises (Text with EEA relevance) (revoked)
EU Regulation No 668/2009 · Adopted 24 July 2009 · Extends to United Kingdom
Commission Regulation (EC) No 668/2009
of 24 July 2009
implementing Regulation (EC) No 1394/2007 of the European Parliament and of the Council with regard to the evaluation and certification of quality and non-clinical data relating to advanced therapy medicinal products developed by micro, small and medium-sized enterprises
(Text with EEA relevance) (revoked)
F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Annotations to the whole text
Textual amendments
- F1
Regulation revoked (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 9 para. 1(q) (subject to transitional provisions in S.I. 2012/1916, Sch. 33A); 2020 c. 1, Sch. 5 para. 1(1)
Contents
- 1Scope Repealed
- 2Procedure for evaluation and certification Repealed
- 3Site visits Repealed
- 4Combined advanced therapy medicinal products Repealed
- 5Scientific guidelines Repealed
- 6Report Repealed
- 7Article 7 Repealed
- Signature
1ScopeF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2Procedure for evaluation and certificationF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3Site visitsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4Combined advanced therapy medicinal productsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5Scientific guidelinesF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6ReportF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Signature
F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .